Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Sell

Debt to Equity Rating

Strong Buy

Price to Earnings Rating

Buy

Analyst Rating

Buy

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Sell

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Buy

A

AYTU BioPharma, Inc. Common Stock (AYTU)

Pharmaceutical Preparations

https://www.aytubio.com

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complimentary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. AR101/enzastaurin has received Orphan Drug designation from the FDA. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which it generates maximum revenue from the Rx segment.

7900 E. UNION AVENUE, SUITE 920
DENVER, CO

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

02/15/2008

Market Cap

15,826,675

Shares Outstanding

5,570,000

Weighted SO

5,567,490

Total Employees

N/A

Upcoming Earnings

09/25/2024

Similar Tickers

AQST --.--%

EVOK --.--%

ADMP --.--%

GHSI --.--%

ACRX --.--%

SGIOY --.--%

SBFM --.--%

ALIM --.--%

SXTC --.--%

Beta

-1.4120

Last Div

0.0000

Range

1.52-3.5

Chg

0.0900

Avg Vol

21191

Mkt Cap

15826675

Exch

NASDAQ

Country

US

Phone

720 437 6580

DCF Diff

2.9647

DCF

3.9647

Div Yield

0.0000

P/S

0.1688

EV Multiple

4.3213

P/FV

0.4765

Div Yield %

0.0000

P/E

-1.0716

PEG

-0.0115

Payout

0.0000

Current Ratio

0.8499

Quick Ratio

0.6923

Cash Ratio

0.2361

DSO

116.4981

DIO

148.1037

Op Cycle

264.6018

DPO

117.5917

CCC

147.0101

Gross Margin

0.6532

Op Margin

-0.0153

Pretax Margin

-0.1345

Net Margin

-0.1460

Eff Tax Rate

-0.1877

ROA

-0.1062

ROE

-0.4050

ROCE

-0.0318

NI/EBT

1.0851

EBT/EBIT

8.7882

EBIT/Rev

-0.0153

Debt Ratio

0.2395

D/E

1.0029

LT Debt/Cap

0.1399

Total Debt/Cap

0.5007

Int Coverage

0.5745

CF/Debt

0.2840

Equity Multi

4.1870

Rec Turnover

3.1331

Pay Turnover

3.1040

Inv Turnover

2.4645

FA Turnover

33.9457

Asset Turnover

0.7276

OCF/Share

1.5840

FCF/Share

1.5840

Cash/Share

3.5709

OCF/Sales

0.0935

FCF/OCF

1.0000

CF Coverage

0.2840

ST Coverage

0.3389

CapEx Coverage

0.0000

Div&CapEx Cov

0.0000

P/BV

0.4765

P/B

0.4765

P/S

0.1688

P/E

-1.0716

P/FCF

1.8057

P/OCF

1.6730

P/CF

1.6730

PEG

-0.0115

P/S

0.1688

EV Multiple

4.3213

P/FV

0.4765

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation